Optimizing Cardiovascular Health: Advancements in LDL Cholesterol Management through Intensive and Early Treatment Strategies - Episode 12

Overcoming Prior Authorization Barriers in LDL Cholesterol Therapies

Published on: 
, , , ,

Michael Koren, MD addresses the challenges posed by prior authorization and the diminished role of pharmaceutical sales representatives in informing providers about medication advancements, leading to a disconnect in the provider's treatment arsenal.

Video content above is prompted by the following questions:

  • How does your office handle payer approval/prior authorization for lipid lower medication? Are there any tips to help with getting approval?
  • How is help with co pay assistance programs coordinated in your practice to help increase accessibility and affordability?